Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8477 in Peripheral Neuropathic Pain
NCT02065349Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ASP8477 in diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), sponsored by Astellas Pharma. Started Feb 2014; status: completed.
02
Drugs
ASP8477
03
Conditions
diabetic peripheral neuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02065349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065349.